Effect of endothelin antagonists on the responses to prostanoid endothelium-derived contracting factor

British Journal of Pharmacology

Volumn 118, Issue 6, 1996, Pages 1429-1432

  Moreau, Pierre ^a   Takase, Hiroyuki ^a   Lüscher, Thomas F ^a  

^a University Hospital of Psychiatry   (Switzerland)

Author keywords

Bosentan; EDCF; Endothelin antagonists; Endothelin 1; Endothelium; PD147953; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 7 [3 [(2 HEPTANAMIDOACETAMIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; ARGININE METHYL ESTER; BOSENTAN; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RECEPTOR BLOCKING; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0029884838     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15556.x     Document Type: Article

References (14)

1. AUCH-SCHWELK, W., KATUSIC, Z.S. & VANHOUTTE, P.M. (1990). Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension, 15, 699-703.
2. CLOZEL, M., BREU, V., GRAY, G.A., KALINA, B., LÖFFLER, B.-M., BURRI, K., CASSAL, J.-M., HIRTH, G., MÜLLER, M., NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
3. 2 in the SHR aorta. Circ. Res., 76, 1003-1010.
4. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension, 15, 475-482.
5. KIOWSKI, W., SÜTSCH, G., HUNZIKER, P., MÜLLER, P., KIM, J., OECHSLIN, E., SCHMITT, R., JONES, R. & BERTEL, O. (1995). Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet, 346, 732-736.
6. KÜNG, C.F. & LÜSCHER, T.F. (1995). Different mechanism of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension, 25, 194-200.
7. KÜNG, C.F., MOREAU, P., TAKASE, H. & LÜSCHER, T.F. (1995). L-NAME induced hypertension impairs endothelial function in rat aorta: Reversal by trandolapril and verapamil. Hypertension, (in press).
8. LIN, L. & ASJLETTI, A. (1992). Prostanoid-mediated vascular contraction in normotensive and hypertensive rats. Eur. J. Pharmacol., 220, 49-53.
9. LÜSCHER, T.F., BOULANGER, C.M., DOHI, Y. & YANG, Z.H. (1992). Endothelium-derived contracting factors. Hypertension, 19, 117-130.
10. SOGABE, K., NIREI, H., SHOUBO, M., NOMOTO, A., AO, S., NOTSU, Y. & ONO, T. (1993). Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. J. Pharmacol. Exp. Ther., 264, 1040-1046.
11. TADDEI, S. & VANHOUTTE, P.M. (1993). Role of endothelium in endothelin-evoked contractions in the rat aorta. Hypertension, 21, 9-15.
12. TADDEI, S., VIRDIS, A., MATTEI, P. & SALVETTI, A. (1993). Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension, 21, 929-933.
13. TAKASE, H., MOREAU, P. & LÜSCHER, T.F. (1995). Endothelin receptor subtypes in small arteries: Studies with FR139317 and bosentan. Hypertension. 25 (part 2), 739-743.
14. WALLENSTEIN, S., ZUCKER, C.L. & FLEISS, J.L. (1980). Some statistical methods useful in circulation research. Circ. Res., 47, 1-9.